ravulizumab
pharmaceutical drug
Facts
4 properties- Instance of
- monoclonal antibody, medication, pharmaceutical product[1][2]
- Legal status (medicine)
- boxed warning[7]
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*[8]
- Medical condition treated
- paroxysmal nocturnal hemoglobinuria, myasthenia gravis, neuromyelitis optica, atypical hemolytic uremic syndrome[3][4][5][6]
🏷️ Also known as
en ALXN1210
en ravulizumab
en Ultomiris
ar رافوليزوماب
he רבוליזומאב
pt Ravulizumabe
uk равулізумаб
zh 拉夫利珠單抗
🔖 Identifiers · 11
- Image (Wikimedia Commons)
- Equipment - Syringe -- Smart-Servier.png ↗
- CAS Registry Number
- 1803171-55-2
- DrugBank ID
- DB11580
- Google Knowledge Graph ID
- /g/11f4qfcb5z
- Guide to Pharmacology Ligand ID
- 10168
- KEGG ID
- D11054
- LiverTox ID
- Ravulizumab
- MedlinePlus drug identifier
- a619014
- RxNorm CUI
- 2107301
- UNII
- C3VX249T6L
- WikiProjectMed ID
- Ravulizumab
🔗 Connections
Instance of 2
Legal status (medicine) 1
← Drug or therapy used for treatment 1
← Product or material produced 1
Press Enter · cited answer in seconds